Erratum: Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer

Objective : To evaluate the significance of preoperative neutrophil-lymphocyte ratio (NLR) for the analysis of disease-free survival (DFS) and overall survival (OS) in patients with stage II colorectal cancer (CRC).Summary of Background Data: Previous reports have indicated the association of NLR with a poor prognosis and tumor progression in patients with CRC. However, the role of NLR as a prognostic marker specifically in patients with stage II CRC has not been well studied.Methods : A total of 124 colon cancer patients were included in the study. The OS and DFS of patients were compared using preoperative NLR. Univariate and multivariate analyses using the Cox proportional hazards model were performed to determine the prognostic value of NLR.Results : The OS and DFS of patients with an NLR ≥ 4.0 were significantly lower when compared with those of patients with an NLR< 4.0. Multivariate analysis showed that NLR ≥ 4.0, PS score ≥ 1, and depth of tumor invasion T4 were independent prognostic factors for DFS, whereas age above 80 years, NLR ≥ 4.0, and PS score ≥ 1 were independent prognostic factors for OS.Conclusions : NLR can be considered a poor prognostic factor in patients with stage II CRC after curative surgery.

Download Full-text

Postoperative day five neutrophil-lymphocyte ratio behaves as an independent prognostic factor in patients with pancreatic cancer

HPB ◽

10.1016/j.hpb.2020.11.679 ◽

2021 ◽

Vol 23 ◽

pp. S269

Author(s):

P. Marcos-Santos ◽

M. Bailon-Cuadrado ◽

B. Perez-Saborido ◽

E. Asensio-Diaz ◽

P. Pinto-Fuentes ◽

...

Keyword(s):

Pancreatic Cancer ◽

Prognostic Factor ◽

Independent Prognostic Factor ◽

Neutrophil Lymphocyte Ratio ◽

Lymphocyte Ratio

Download Full-text

The prognostic and diagnostic significance of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: a prospective controlled study

British Journal of Cancer ◽

10.1038/s41416-021-01445-3 ◽

2021 ◽

Author(s):

Philip J. Johnson ◽

Sofi Dhanaraj ◽

Sarah Berhane ◽

Laura Bonnett ◽

Yuk Ting Ma

Keyword(s):

Hepatocellular Carcinoma ◽

Regression Analysis ◽

Prognostic Factor ◽

Cox Regression ◽

Prognostic Models ◽

Controlled Study ◽

Cox Regression Analysis ◽

Neutrophil Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Significant Difference

Abstract Background The neutrophil–lymphocyte ratio (NLR), a presumed measure of the balance between neutrophil-associated pro-tumour inflammation and lymphocyte-dependent antitumour immune function, has been suggested as a prognostic factor for several cancers, including hepatocellular carcinoma (HCC). Methods In this study, a prospectively accrued cohort of 781 patients (493 HCC and 288 chronic liver disease (CLD) without HCC) were followed-up for more than 6 years. NLR levels between HCC and CLD patients were compared, and the effect of baseline NLR on overall survival amongst HCC patients was assessed via multivariable Cox regression analysis. Results On entry into the study (‘baseline’), there was no clinically significant difference in the NLR values between CLD and HCC patients. Amongst HCC patients, NLR levels closest to last visit/death were significantly higher compared to baseline. Multivariable Cox regression analysis showed that NLR was an independent prognostic factor, even after adjustment for the HCC stage. Conclusion NLR is a significant independent factor influencing survival in HCC patients, hence offering an additional dimension in prognostic models.

Download Full-text

The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients

International Journal of Molecular Sciences ◽

10.3390/ijms18040730 ◽

2017 ◽

Vol 18 (4) ◽

pp. 730 ◽

Cited By ~ 24

Author(s):

Matteo Piciucchi ◽

Serena Stigliano ◽

Livia Archibugi ◽

Giulia Zerboni ◽

Marianna Signoretti ◽

...

Keyword(s):

Pancreatic Cancer ◽

Cancer Patients ◽

Metastatic Pancreatic Cancer ◽

Neutrophil Lymphocyte Ratio ◽

Lymphocyte Ratio

Download Full-text

Neutrophil-lymphocyte ratio as a prognostic factor for stereotactic body radiotherapy treatment of metastatic liver tumors

Translational Cancer Research ◽

10.21037/tcr-20-1335a ◽

2020 ◽

Vol 9 (9) ◽

pp. 5566-5573

Author(s):

Xuyun Xie ◽

Jingjing Shan ◽

Xuan Zhou ◽

Hai Liu ◽

Xiaonan Sun

Keyword(s):

Prognostic Factor ◽

Stereotactic Body Radiotherapy ◽

Liver Tumors ◽

Neutrophil Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Metastatic Liver Tumors ◽

Radiotherapy Treatment ◽

Metastatic Liver

Download Full-text

Preoperative Platelet to Lymphocyte Ratio as a Prognostic Factor for Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis

Digestive Surgery ◽

10.1159/000508444 ◽

2020 ◽

Vol 37 (6) ◽

pp. 447-455

Author(s):

Romualdas Riauka ◽

Povilas Ignatavicius ◽

Giedrius Barauskas

Keyword(s):

Systematic Review ◽

Pancreatic Cancer ◽

Prognostic Factor ◽

Meta Analysis ◽

Disease Free Survival ◽

Platelet To Lymphocyte Ratio ◽

Resectable Pancreatic Cancer ◽

Lymphocyte Ratio ◽

Asian Patients ◽

Hazard Ratios

Introduction: Various inflammatory markers have been investigated for a prognostic role in patients with resectable pancreatic cancer. However, the value of preoperative platelet to lymphocyte ratio (PLR) remains controversial. We performed a systematic review and meta-analysis of PLR as a preoperative prognostic factor for resectable pancreatic cancer. Material and Methods: Systematic literature search was conducted for studies assessing PLR influence as a preoperative prognostic factor in resectable pancreatic cancer patients. Random-effects model was applied for pooling hazard ratios and 95% confidence intervals related to overall survival (OS) and disease-free survival (DFS). Results: Fourteen articles with 2,743 patients were included in the study. According to the analysis, high PLR had no correlation with decreased OS. Due to high heterogeneity among studies, subgroup analysis was performed. Better OS was associated with low PLR in Asian patients, patients with mixed type of operation performed, and patients with preoperative PLR ≤150. Low PLR was associated with significantly better DFS. Conclusions: PLR is a predictive factor of better DFS in patients with resectable pancreatic cancer. However, available evidence does not support PLR as a reliable prognostic factor for OS.

Download Full-text